Alfra Dixon

Recommended Articles

• Is Leukemia Genetic?

  Leukemia is a type of cancer that usually begins in the bone marrow and can cause an increase in the growth of abnormal white blood cells, severely impairing the immune system of the body. There are primarily four types of leukemia, including acute myeloid leukaemia, acute lymphoblastic leukaemia,...

• What Type of Disease is Meningitis?

  To what extent do you understand the meningitis disease? You may be aware that it is a condition that is life-threatening and that it inflames the spinal cord and brain – and you'd be correct! The meninges is the collective name for the three membranes that envelope the brain and spinal cord...

• What Are the Causes of Edema in the Legs?

  Edema is the medical term used for swelling. Swelling can affect a particular part of the body or the entire body due to some injury or inflammation. Apart from this, the other factors that can cause edema are side effects of certain medications, infections, pregnancy and few other medical...

• Why Does Alzheimer’s Progress More Rapidly for Some Than for Others?

  Alzheimer’s disease is a progressive disease. Over a period of many years, symptoms will slowly become more severe, and a person’s overall condition will worsen. Each person experiences a different progression of symptoms over a different stretch of time, though many will experience slow-moving...

• Tips for Preparing Nursing Staff for Natural Disasters

  “Always be prepared” is a well-known Scouting motto. For medical professionals, especially for nurses, this motto rings particularly true.  Since nurses are often referred to ‘as the most trusted professionals in healthcare’, patients will often turn to them for help and advice on anything...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...